Repligen (RGEN) stock gains as HSBC launched its coverage with a Buy recommendation, citing attractive growth prospects for the life sciences company. Read more here.
Repligen higher as HSBC initiates with Buy (RGEN:NASDAQ)
Repligen (RGEN) stock gains as HSBC launched its coverage with a Buy recommendation, citing attractive growth prospects for the life sciences company. Read more here.